CNPT 101101
Alternative Names: CNPT‐101101Latest Information Update: 28 Dec 2023
At a glance
- Originator FronThera US Pharmaceuticals
- Class Antifibrotics; Hepatoprotectants; Small molecules
- Mechanism of Action Thyroid hormone receptor beta agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Non-alcoholic steatohepatitis
Most Recent Events
- 28 Dec 2023 No recent reports of development identified for preclinical development in Non-alcoholic-steatohepatitis in USA
- 08 Nov 2019 Pharmacodynamics data from preclinical trials in Non-alcoholic steatohepatitis presented at the The Liver Meeting 2019: 70th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2019)